lunes, 22 de abril de 2013

NCI think tank concerning the identifiability of biospecimens and [ldquo]omic[rdquo] data : Genetics in Medicine : Nature Publishing Group

full-text ►
NCI think tank concerning the identifiability of biospecimens and [ldquo]omic[rdquo] data : Genetics in Medicine : Nature Publishing Group

NCI think tank concerning the identifiability of biospecimens and “omic” data

Genetics in Medicine
(2013)
doi:10.1038/gim.2013.40
Received
Accepted
Published online

Abstract

Purpose: On 11 and 12 June 2012, the National Cancer Institute hosted a think tank concerning the identifiability of biospecimens and “omic” data in order to explore challenges surrounding this complex and multifaceted topic.
Methods: The think tank brought together 46 leaders from several fields, including cancer genomics, bioinformatics, human subject protection, patient advocacy, and commercial genetics.
Results: The first day involved presentations regarding the state of the science of reidentification; current and proposed regulatory frameworks for assessing identifiability; developments in law, industry, and biotechnology; and the expectations of patients and research participants. The second day was spent by think tank participants in small breakout groups designed to address specific subtopics under the umbrella issue of identifiability, including considerations for the development of best practices for data sharing and consent, and targeted opportunities for further empirical research.
Conclusion: We describe the outcomes of this 2-day meeting, including two complementary themes that emerged from moderated discussions following the presentations on day 1, and ideas presented for further empirical research to discern the preferences and concerns of research participants about data sharing and individual identifiability.
Genet Med advance online publication 11 April 2013

Keywords:

biospecimens; data sharing; identifiability; research participant engagement

No hay comentarios: